Saltar al contenido principal

Advances in Cystic Fibrosis, An Issue of Clinics in Chest Medicine

  • 1 Edición, Volumen 43-4 - 9 de noviembre de 2022
  • Última edición
  • Editores: Clemente J. Britto, Jennifer L. Taylor-Cousar
  • Idioma: Inglés

In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis.… Leer más

Descripción

In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis. Top experts in the field cover key topics such as genetics of cystic fibrosis (CF): clinical implications; innate and adaptive immunity in CF; novel applications of biomarkers and personalized medicine to define the spectrum of CF; emerging approaches to understand CF pathogenesis; and more.

Puntos claves

  • Contains 18 relevant, practice-oriented topics including novel approaches to multidrug resistant infections in CF; clinical outcomes of highly-effective modulator therapy; nontuberculous mycobacterial infections in CF; management of mental health in CF; sexual and reproductive health in CF; nutritional management in CF; transitions of care in CF; and more.

  • Provides in-depth clinical reviews on advances in cystic fibrosis, offering actionable insights for clinical practice.

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

De interès para

Chest Medicine/Pulmonary

Índice

Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations
Genetics of Cystic Fibrosis: Clinical Implications
Update on Innate and Adaptive Immunity in Cystic Fibrosis
Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis
Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis
Update on Clinical Outcomes of Highly Effective Modulator Therapy
Nontuberculous Mycobacterial Infections in Cystic Fibrosis
Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Transitions of Care in Cystic Fibrosis
Endocrine Complications of Cystic Fibrosis
Management of Mental Health in Cystic Fibrosis
Family Planning and Reproductive Health in Cystic Fibrosis
Update on Lung Transplantation for Cystic Fibrosis

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 43-4
  • Publicado: 11 de noviembre de 2022
  • Idioma: Inglés

Sobre los editores

CB

Clemente J. Britto

Afiliaciones y experiencia
Assistant Professor of Medicine, Adult Cystic Fibrosis Program, Center for Pulmonary Infection Research and, Treatment (CPIRT) Section of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine

JT

Jennifer L. Taylor-Cousar

Afiliaciones y experiencia
Medical Director, Clinical Research Services, Co-Director and CF TDC Director, Adult CF, Program, Professor, Departments of Medicine and Pediatrics, Divisions of Pulmonary, Critical Care and Sleep Medicine and Pediatric Pulmonary Medicine Divisions of Pulmonary Sciences and Critical Care Medicine and Pediatric Pulmonology University of Colorado Anschutz Medical Campus National Jewish Health